Intra-Cellular Therapies Statistics
Total Valuation
BOM:532928 has a market cap or net worth of INR 147.47 billion. The enterprise value is 148.06 billion.
Market Cap | 147.47B |
Enterprise Value | 148.06B |
Important Dates
The next estimated earnings date is Wednesday, October 8, 2025.
Earnings Date | Oct 8, 2025 |
Ex-Dividend Date | May 9, 2025 |
Share Statistics
BOM:532928 has 300.17 million shares outstanding. The number of shares has increased by 7.40% in one year.
Current Share Class | 300.17M |
Shares Outstanding | 300.17M |
Shares Change (YoY) | +7.40% |
Shares Change (QoQ) | +1.21% |
Owned by Insiders (%) | 68.22% |
Owned by Institutions (%) | 12.29% |
Float | 95.25M |
Valuation Ratios
The trailing PE ratio is 56.47 and the forward PE ratio is 37.50.
PE Ratio | 56.47 |
Forward PE | 37.50 |
PS Ratio | 6.62 |
PB Ratio | 11.59 |
P/TBV Ratio | 11.96 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 56.61 |
EV / Sales | 6.65 |
EV / EBITDA | 39.98 |
EV / EBIT | 42.83 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.22 |
Debt / EBITDA | 0.76 |
Debt / FCF | n/a |
Interest Coverage | 10.55 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | 18.20% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 40.27M |
Profits Per Employee | 4.73M |
Employee Count | 553 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:532928 has paid 844.80 million in taxes.
Income Tax | 844.80M |
Effective Tax Rate | 24.31% |
Stock Price Statistics
The stock price has increased by +38.14% in the last 52 weeks. The beta is -0.27, so BOM:532928's price volatility has been lower than the market average.
Beta (5Y) | -0.27 |
52-Week Price Change | +38.14% |
50-Day Moving Average | 503.17 |
200-Day Moving Average | 491.14 |
Relative Strength Index (RSI) | 44.23 |
Average Volume (20 Days) | 115,807 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:532928 had revenue of INR 22.27 billion and earned 2.62 billion in profits. Earnings per share was 8.70.
Revenue | 22.27B |
Gross Profit | 7.13B |
Operating Income | 3.46B |
Pretax Income | 3.48B |
Net Income | 2.62B |
EBITDA | 3.70B |
EBIT | 3.46B |
Earnings Per Share (EPS) | 8.70 |
Balance Sheet
The company has 2.44 billion in cash and 2.83 billion in debt, giving a net cash position of -383.36 million or -1.28 per share.
Cash & Cash Equivalents | 2.44B |
Total Debt | 2.83B |
Net Cash | -383.36M |
Net Cash Per Share | -1.28 |
Equity (Book Value) | 12.72B |
Book Value Per Share | 41.71 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 32.03%, with operating and profit margins of 15.53% and 11.75%.
Gross Margin | 32.03% |
Operating Margin | 15.53% |
Pretax Margin | 15.61% |
Profit Margin | 11.75% |
EBITDA Margin | 16.63% |
EBIT Margin | 15.53% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 0.04%.
Dividend Per Share | 0.20 |
Dividend Yield | 0.04% |
Dividend Growth (YoY) | 100.00% |
Years of Dividend Growth | 1 |
Payout Ratio | n/a |
Buyback Yield | -7.40% |
Shareholder Yield | -7.36% |
Earnings Yield | 1.77% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
The last stock split was on February 14, 2025. It was a forward split with a ratio of 2.
Last Split Date | Feb 14, 2025 |
Split Type | Forward |
Split Ratio | 2 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |